Stockreport

enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc.

enGene Holdings Inc.  (ENGN) 
PDF Up to $100 million in additional loan proceeds provide additional financial flexibility to advance detalimogene development and commercialization for bladder cancer$25 m [Read more]